Size :50ug
Clone Number:
Aliases:GalNAc T9 antibody; GalNAc transferase 9 antibody; GalNAc-T9 antibody; GALNT9 antibody; GALT9_HUMAN antibody; Polypeptide GalNAc transferase 9 antibody; Polypeptide N acetylgalactosaminyltransferase 9 antibody; Polypeptide N-acetylgalactosaminyltransferase 9 antibody; pp GaNTase 9 antibody; pp-GaNTase 9 antibody; Protein UDP acetylgalactosaminyltransferase 9 antibody; Protein-UDP acetylgalactosaminyltransferase 9 antibody; UDP GalNAc polypeptide N acetylgalactosaminyltransferase 9 antibody; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9 antibody; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) antibody
Product Type:Polyclonal Antibody
Immunogen Species:Homo sapiens (Human)
UniProt ID:Q9HCQ5
Immunogen:Recombinant Human Polypeptide N-acetylgalactosaminyltransferase 9 protein (184-338AA)
Raised in:Rabbit
Species Reactivity:Human
Tested Applications:ELISA, WB; Recommended dilution: WB:1:500-1:5000
Background:Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Does not glycosylate apomucin or SDC3.
Clonality:Polyclonal
Isotype:IgG
Purification Method:>95%, Protein G purified
Conjugate:Non-conjugated
Buffer:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form:Liquid
Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Names:GALNT9
Research Areas:Cancer;Metabolism;Signal transduction